150 related articles for article (PubMed ID: 32205094)
21. 24-norUrsodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice.
Fickert P; Wagner M; Marschall HU; Fuchsbichler A; Zollner G; Tsybrovskyy O; Zatloukal K; Liu J; Waalkes MP; Cover C; Denk H; Hofmann AF; Jaeschke H; Trauner M
Gastroenterology; 2006 Feb; 130(2):465-81. PubMed ID: 16472600
[TBL] [Abstract][Full Text] [Related]
22. Effect of mdr2 mutation with combined tandem disruption of canalicular glycoprotein transporters by cyclosporine A on bile formation in mice.
Elamiri A; Perwaiz S; Tuchweber B; Yousef IM
Pharmacol Res; 2003 Nov; 48(5):467-72. PubMed ID: 12967592
[TBL] [Abstract][Full Text] [Related]
23. Hydrophilic bile acids prevent liver damage caused by lack of biliary phospholipid in
Wang R; Sheps JA; Liu L; Han J; Chen PSK; Lamontagne J; Wilson PD; Welch I; Borchers CH; Ling V
J Lipid Res; 2019 Jan; 60(1):85-97. PubMed ID: 30416103
[TBL] [Abstract][Full Text] [Related]
24. Disruption of BSEP Function in HepaRG Cells Alters Bile Acid Disposition and Is a Susceptive Factor to Drug-Induced Cholestatic Injury.
Qiu X; Zhang Y; Liu T; Shen H; Xiao Y; Bourner MJ; Pratt JR; Thompson DC; Marathe P; Humphreys WG; Lai Y
Mol Pharm; 2016 Apr; 13(4):1206-16. PubMed ID: 26910619
[TBL] [Abstract][Full Text] [Related]
25. Expression Analysis of ATP-Binding Cassette Transporters ABCB11 and ABCB4 in Primary Sclerosing Cholangitis and Variety of Pediatric and Adult Cholestatic and Noncholestatic Liver Diseases.
Thoeni C; Waldherr R; Scheuerer J; Schmitteckert S; Roeth R; Niesler B; Cutz E; Flechtenmacher C; Goeppert B; Schirmacher P; Lasitschka F
Can J Gastroenterol Hepatol; 2019; 2019():1085717. PubMed ID: 31886153
[TBL] [Abstract][Full Text] [Related]
26. Cenicriviroc, a cytokine receptor antagonist, potentiates all-trans retinoic acid in reducing liver injury in cholestatic rodents.
Yu D; Cai SY; Mennone A; Vig P; Boyer JL
Liver Int; 2018 Jun; 38(6):1128-1138. PubMed ID: 29356312
[TBL] [Abstract][Full Text] [Related]
27. Lessons from the toxic bile concept for the pathogenesis and treatment of cholestatic liver diseases.
Trauner M; Fickert P; Halilbasic E; Moustafa T
Wien Med Wochenschr; 2008; 158(19-20):542-8. PubMed ID: 18998069
[TBL] [Abstract][Full Text] [Related]
28. Hepatocyte IKK2 protects Mdr2-/- mice from chronic liver failure.
Ehlken H; Kondylis V; Heinrichsdorff J; Ochoa-Callejero L; Roskams T; Pasparakis M
PLoS One; 2011; 6(10):e25942. PubMed ID: 22022477
[TBL] [Abstract][Full Text] [Related]
29. Improvement of hepatocyte transplantation efficiency in the mdr2-/- mouse model by glyceryl trinitrate.
Boudechiche L; Tranchart H; Branchereau S; Davit-Spraul A; Laïnas P; Groyer-Picard MT; Weber A; Hadchouel M; Dagher I
Transplantation; 2015 Jan; 99(1):36-40. PubMed ID: 25340599
[TBL] [Abstract][Full Text] [Related]
30. Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles.
Fickert P; Zollner G; Fuchsbichler A; Stumptner C; Weiglein AH; Lammert F; Marschall HU; Tsybrovskyy O; Zatloukal K; Denk H; Trauner M
Gastroenterology; 2002 Oct; 123(4):1238-51. PubMed ID: 12360485
[TBL] [Abstract][Full Text] [Related]
31. Pharmacological inhibition of apical sodium-dependent bile acid transporter changes bile composition and blocks progression of sclerosing cholangitis in multidrug resistance 2 knockout mice.
Miethke AG; Zhang W; Simmons J; Taylor AE; Shi T; Shanmukhappa SK; Karns R; White S; Jegga AG; Lages CS; Nkinin S; Keller BT; Setchell KD
Hepatology; 2016 Feb; 63(2):512-23. PubMed ID: 26172874
[TBL] [Abstract][Full Text] [Related]
32. WNT7B Regulates Cholangiocyte Proliferation and Function During Murine Cholestasis.
Kosar K; Cornuet P; Singh S; Lee E; Liu S; Gayden J; Sato T; Freyberg Z; Arteel G; Nejak-Bowen K
Hepatol Commun; 2021 Dec; 5(12):2019-2034. PubMed ID: 34558852
[TBL] [Abstract][Full Text] [Related]
33. Defective canalicular transport and toxicity of dietary ursodeoxycholic acid in the abcb11-/- mouse: transport and gene expression studies.
Wang R; Liu L; Sheps JA; Forrest D; Hofmann AF; Hagey LR; Ling V
Am J Physiol Gastrointest Liver Physiol; 2013 Aug; 305(4):G286-94. PubMed ID: 23764895
[TBL] [Abstract][Full Text] [Related]
34. Inflammation Drives MicroRNAs to Limit Hepatocyte Bile Acid Transport in Murine Biliary Atresia.
Azeltine MW; Chavez EJ; Nemec KM; Bednarek JM; Asokan R; Balasubramaniyan N; Zgheib C; Mack CL; Roach JP
J Surg Res; 2020 Dec; 256():663-672. PubMed ID: 32818799
[TBL] [Abstract][Full Text] [Related]
35. Sobetirome and its Amide Prodrug Sob-AM2 Exert Thyromimetic Actions in Mct8-Deficient Brain.
Bárez-López S; Hartley MD; Grijota-Martínez C; Scanlan TS; Guadaño-Ferraz A
Thyroid; 2018 Sep; 28(9):1211-1220. PubMed ID: 29845892
[TBL] [Abstract][Full Text] [Related]
36. Sobetirome: a selective thyromimetic for the treatment of dyslipidemia.
Tancevski I; Demetz E; Eller P
Recent Pat Cardiovasc Drug Discov; 2011 Jan; 6(1):16-9. PubMed ID: 21208155
[TBL] [Abstract][Full Text] [Related]
37. Sobetirome: a case history of bench-to-clinic drug discovery and development.
Scanlan TS
Heart Fail Rev; 2010 Mar; 15(2):177-82. PubMed ID: 19002578
[TBL] [Abstract][Full Text] [Related]
38. The Epidermal Growth Factor Receptor Ligand Amphiregulin Protects From Cholestatic Liver Injury and Regulates Bile Acids Synthesis.
Santamaría E; Rodríguez-Ortigosa CM; Uriarte I; Latasa MU; Urtasun R; Alvarez-Sola G; Bárcena-Varela M; Colyn L; Arcelus S; Jiménez M; Deutschmann K; Peleteiro-Vigil A; Gómez-Cambronero J; Milkiewicz M; Milkiewicz P; Sangro B; Keitel V; Monte MJ; Marin JJG; Fernández-Barrena MG; Ávila MA; Berasain C
Hepatology; 2019 Apr; 69(4):1632-1647. PubMed ID: 30411380
[TBL] [Abstract][Full Text] [Related]
39. Bile acids initiate cholestatic liver injury by triggering a hepatocyte-specific inflammatory response.
Cai SY; Ouyang X; Chen Y; Soroka CJ; Wang J; Mennone A; Wang Y; Mehal WZ; Jain D; Boyer JL
JCI Insight; 2017 Mar; 2(5):e90780. PubMed ID: 28289714
[TBL] [Abstract][Full Text] [Related]
40. The role of long noncoding RNA H19 in gender disparity of cholestatic liver injury in multidrug resistance 2 gene knockout mice.
Li X; Liu R; Yang J; Sun L; Zhang L; Jiang Z; Puri P; Gurley EC; Lai G; Tang Y; Huang Z; Pandak WM; Hylemon PB; Zhou H
Hepatology; 2017 Sep; 66(3):869-884. PubMed ID: 28271527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
